Obesity (body mass index ≥30 kg/m2) is a broadly accepted risk factor of systemic insulin resistance [8], and loss of skeletal muscle insulin sensitivity is the first sign of such resistance in human subjects [2]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.